Hong Kong-based healthcare company Prenetics ($PRE) has deepened its Bitcoin strategy, purchasing an additional 110 Bitcoins, bringing its total holdings to 378 Bitcoins, worth about $41 million, according to a company disclosure.
This move strengthens Prenetics’ collaboration between biotech innovation and digital asset management. Continue The recent $44 million equity financing closed on October 28, 2025.
Healthcare companies turn Bitcoin bull market
Nasdaq-listed Prenetics first surprised investors earlier this year when it began allocating its financial reserves to Bitcoin. The company has now increased its position by 100 BTC with an average acquisition price of $109,594.
According to the latest Bitcoin Treasury rankings, Prenetics currently ranks 72nd among publicly traded companies that hold BTC.
The company’s balance sheet remains strong, with total liquidity of $127 million, including $86 million in cash and $41 million in Bitcoin. This fusion of fiat and crypto liquidity highlights what the company calls a “dual engine” strategy that combines growth in healthcare innovation with digital asset exposure.
JUST IN: Publicly traded healthcare company Prenetics $PRE Purchased 110 additional pieces #bitcoin Currently, I have a total of 378 BTC.
🔸Bitcoin 100 ranking: 72nd place🪜🔸 pic.twitter.com/xbu18yl8Eb
— BitcoinTreasuries.NET (@BTCtreasuries) October 31, 2025
Utilize capital from oversubscribed stock offerings
The recent Bitcoin purchase marks the first major use of proceeds from Prenetics’ $44 million stock offering, which closed days before the announcement.
The call was heavily oversubscribed and attracted a diverse range of strategic investors, including Kraken, Exodus, GPTX (founded by Bitdeer’s Jihan Wu), XtalPi, DL Holdings, and even world tennis champion Aryna Sabalenka.
According to Prenetics, the participation of such prominent backers validates the company’s strategy to bridge two fast-growing fields: medical innovation and blockchain-based financial management.
The move also highlights how Bitcoin is evolving from a speculative asset to a legitimate corporate reserve tool for public companies across a variety of industries.
Strategic collaboration between health tech and cryptocurrencies
Prenetics’ approach is unusual, but increasingly strategic. The company is not pivoting away from healthcare; it is strengthening it with financial stability backed by a diversified asset base.
By pegging a portion of its treasury to Bitcoin, Prenetics aims to leverage BTC’s long-term upside potential while offsetting traditional currency risks.
The move follows a growing trend of non-cryptocurrency companies integrating Bitcoin into their financial management, a list that includes companies from energy to technology and now healthcare.
Market situation: Big Bitcoin holders continue to make profits
This movement also applies to times when Bitcoin is performing well.
As of late October 2025, Bitcoin was trading at around $109,000, according to CoinMarketCap, continuing its strong year-to-date gains supported by institutional inflows and ETF demand.
Meanwhile, Strategy, one of the world’s largest corporate Bitcoin holders, reported its third quarter 2025 results with operating income of $3.9 billion and net income of $2.8 billion. The company’s Bitcoin holding profits have increased by $12.9 billion since the beginning of the year, generating a 26% BTC yield across its 640,808 BTC holdings.
Strategy reaffirmed its full-year 2025 guidance of $34 billion in operating profit and $20 billion in Bitcoin profit, demonstrating growing confidence among institutional investors in Bitcoin’s long-term trajectory.
Against this backdrop, Prenetics’ recent BTC purchases appear to be less speculative and more strategic, with the healthcare company positioned to participate in the asset’s broader market rally.
Strategy releases third quarter 2025 results and reaffirms 2025 guidance.
Third quarter results: operating income of $3.9 billion, net income of $2.8 billion, diluted EPS of $8.42
FY2025 guidance: Operating profit $34 billion, BTC profit $20 billion https://t.co/BizC9HyJLD— Strategy (@Strategy) October 30, 2025
Hybrid model for the future
Prenetics’ dual-focus model, combining biotechnology research and blockchain-backed asset management, continues to attract investor attention.
Company leadership describes this approach as a “hybrid growth model” designed to increase capital efficiency while maintaining aggressive innovation within the health industry.
By integrating Bitcoin as a balance sheet asset, Prenetics can protect its reserves from currency devaluation and demonstrate confidence to institutional investors seeking publicly traded companies that are financially agile and forward-looking.
Bitcoin as a balance sheet strategy
The concept of holding Bitcoin on a company’s balance sheet was once experimental. Today is strategic.
Prenetics’ latest acquisition follows the blueprint pioneered by companies like Strategy and Tesla to consolidate BTC holdings as a long-term inflation hedge and store of value.
The move is unconventional for healthcare companies, but increasingly logical in a macro environment shaped by rising interest rates, fiat currency volatility, and organizations’ digital adoption.
Prenetics’ timing also coincides with growing market optimism regarding Bitcoin ETFs and global regulatory clarity, further strengthening the company’s position as a healthcare pioneer in adopting digital assets at scale.
Investor confidence and market perception
The market has responded positively to Prenetics’ transparency in its financial operations. This announcement includes accurate numbers and clear rationale, demonstrating maturity and risk management discipline.
As the company continues to focus on medical innovation, its Bitcoin allocation can further increase shareholder value.
Given the support from prominent strategic investors and the liquidity provided by the equity raise, Prenetics is now well-positioned to expand both its R&D initiatives and digital asset reserves.
Prenetics’ latest Bitcoin purchase could be a turning point not just for the company, but for corporate finance practices across the board.
By combining healthcare innovation with blockchain-based balance sheet strategies, the company is demonstrating how traditional industries can integrate decentralized assets into their long-term capital frameworks.
As Bitcoin continues to mature and outperform major asset classes, companies like Prenetics are proving that corporate diversification is no longer limited to stocks and bonds and extends to the digital frontier.
Disclosure: This is not trading or investment advice. Always do your research before purchasing any cryptocurrency or investing in any service.
Follow us on Twitter @themerklehash Stay up to date with the latest crypto, NFT, AI, cybersecurity, and metaverse news.